Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patients
贝伐单抗停药与2型神经纤维瘤病相关神经鞘瘤患者的前庭神经鞘瘤反弹生长有关。
期刊:NeuroOncology Advances
影响因子:4.1
doi:10.1093/noajnl/vdad123
Webb, M J; Neth, Bryan J; Webb, Lauren M; Van Gompel, Jamie J; Link, Michael J; Neff, Brian A; Carlson, Matthew L; Driscoll, Colin L; Dornhoffer, Jim; Ruff, Michael W; Anderson, Kelsey A; Kizilbash, Sani H; Campian, Jian L; Uhm, Joon H; Lane, Jack I; Benson, John C; Blezek, Daniel J; Mehta, Parv M; Bathla, Girish; Sener, Ugur T